Login
|
New Account
AAAAAA
ITA
ENG
Results:
1-5
|
Results: 5
Lactoferrin protects neonatal rats from gut-related systemic infection
Authors:
Edde, L Hipolito, RB Hwang, FFY Headon, DR Shalwitz, RA Sherman, MP
Citation:
L. Edde et al., Lactoferrin protects neonatal rats from gut-related systemic infection, AM J P-GAST, 281(5), 2001, pp. G1140-G1150
Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans
Authors:
Griffiths, CEM Cumberbatch, M Tucker, SC Dearman, RJ Andrew, S Headon, DR Kimber, I
Citation:
Cem. Griffiths et al., Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans, BR J DERM, 144(4), 2001, pp. 715-725
Recombinant human lactoferrin is effective in the treatment of Helicobacter felis-infected mice
Authors:
Dial, EJ Romero, JJ Headon, DR Lichtenberger, LM
Citation:
Ej. Dial et al., Recombinant human lactoferrin is effective in the treatment of Helicobacter felis-infected mice, J PHARM PHA, 52(12), 2000, pp. 1541-1546
Regulation of epidermal Langerhans cell migration by lactoferrin
Authors:
Cumberbatch, M Dearman, RJ Uribe-Luna, S Headon, DR Ward, PP Conneely, OM Kimber, I
Citation:
M. Cumberbatch et al., Regulation of epidermal Langerhans cell migration by lactoferrin, IMMUNOLOGY, 100(1), 2000, pp. 21-28
Novel therapies for Helicobacter pylori infection
Authors:
Opekun, AR El-Zaimaity, HMT Osato, MS Gilger, MA Malaty, HM Terry, M Headon, DR Graham, DY
Citation:
Ar. Opekun et al., Novel therapies for Helicobacter pylori infection, ALIM PHARM, 13(1), 1999, pp. 35-41
Risultati:
1-5
|